ULOQ [Study As­sess­ment]

posted by Anand – India, 2017-10-30 06:38  – Posting: # 17945
Views: 6,712

Dear All,

Request to clarify,

In our Pivotal BE Study ULOQ was observed, whether we should exclude from PK?
After Dilution also it found ULOQ.
Method should be redeveloped or revalidated?
If included,What justification we should provide to Regulatory Agency?

Thanks in advance.


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

 Admin contact
20,346 posts in 4,274 threads, 1,405 registered users;
online 61 (0 registered, 61 guests [including 8 identified bots]).
Forum time (Europe/Vienna): 07:19 CET

The belief that there is only one truth and
that oneself is in possession of it,
seems to me the deepest root of all
that is evil in the world.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz